AstraZeneca, Merck ovarian cancer treatment improves progression-free survival
AstraZeneca Plc and Merck & Co Inc said on Monday their treatment for newly diagnosed advanced ovarian
from Reuters: Health News https://ift.tt/2mcqZgV
from Reuters: Health News https://ift.tt/2mcqZgV
Comentarii
Trimiteți un comentariu